Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
01/2004
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/07/2004EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres
01/07/2004CN1465626A Dye and photostabilizer of information recording material thereof
01/06/2004US6673939 Process for the preparation of 1,2,4-triazolin-5-one derivatives
01/06/2004US6673888 Plastic lenses
01/06/2004US6673825 Urazole compounds useful as anti-inflammatory agents
01/06/2004US6673122 Compositions for dyeing keratin fibers containing para-aminophenols, dyeing process, novel para-aminophenols and process for their preparation
01/06/2004CA2285891C Triazole antifungal agents
01/02/2004EP1373599A2 Addition product, production and use thereof as corrosion inhibitor
01/02/2004EP1373283A1 Non-metallocenes, method for the production thereof and the use thereof for the polymerisation of olefins
01/02/2004EP1373227A1 Process for preparing fluconazole and its crystal modifications
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/02/2004EP1372615A1 Compounds and compositions for delivering active agents
01/02/2004EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides
01/01/2004US20040002599 Substituted benzoycyclohexenones
01/01/2004US20040002525 Obesity; osteoporosis
01/01/2004US20040002523 Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
01/01/2004US20040002463 Inhibitors and methods of use thereof
12/2003
12/31/2003WO2004000826A1 Processes for producing epoxytriazole derivative and intermediate therefor
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003CN1132821C 氟化物苯并三唑 Fluoride benzotriazole
12/31/2003CN1132820C Crystal modified body of medicine
12/31/2003CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/30/2003US6670363 Azole compounds as therapeutic agents for fungal infections
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/25/2003WO2003106572A1 Printing process using specified azo compounds
12/25/2003WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
12/25/2003US20030236437 Sulfonation of 1-(5-amino-2,4-dichlorophenyl)-4,5-dihydro-4-difluoromethyl-3-methyl-1,2,4 -triazol-5(1H)-one using mesyl chloride, in the presence of catalysts, to form sulfentrazole used as herbicides or pesticides
12/25/2003US20030236419 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides
12/25/2003US20030236418 Crosslinkable UV-absorbing agent for UV absorbing lens
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003064394A8 5-ring heterocycles used as antiviral agents
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1462746A š�-elemen-5-azacycle ramification and its synthetic method
12/24/2003CN1131864C 吗啉衍生物的化学合成方法 Morpholine derivatives chemical synthesis
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers
12/23/2003US6667307 HIV protease
12/18/2003WO2003105538A1 Electroluminescent device
12/18/2003WO2003104332A1 Compositions and inks containing disazo dyes
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003US20030232786 For prevention and/or treatment of cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease
12/18/2003US20030232717 Ethylene-styrene copolymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
12/18/2003CA2487430A1 Electroluminescent device
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP0871625B1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101972A1 Copper-catalysed ligation of azides and acetylenes
12/11/2003WO2003101936A1 Polymerization catalysts for olefins and process for the production of olefin polymers
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229091 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030228983 Substituted aryl ketones
12/10/2003EP1367888A2 Selective substituted aryl ketone and safener based herbicides
12/10/2003EP1129120B1 Modified polyisocyanates
12/10/2003CN1461300A Process for preparation of benzotriazoles
12/10/2003CN1130124C Fungicidal mixtures
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003CA2189593C Sulphonylaminocarbonyltriazolinones having substituents bonded via oxygen
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2002094186A3 Urazole compounds useful as anti-inflammatory agents
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225072 Opioid receptor active compounds
12/04/2003US20030224941 Uracil substituted phenyl sulfamoyl carboxamides
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1021419B1 Process for preparing triazoline thione derivatives
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220196 Phenyl-substituted-2enamino-keto nitriles
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363626A1 Antifungal remedy formulation for external application
11/25/2003US6653484 Polyoxyalkylene substituted and bridged benzotriazole derivatives
11/25/2003CA2356450C An improved process for the preparation of nefazodone hydrochloride
11/20/2003US20030216581 Textile grafted with bactericide
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/20/2003US20030216385 Triazole derivatives
11/20/2003US20030213164 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
11/19/2003EP1362856A1 Water-soluble triazole fungicide
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003CN1457338A Process for preparation of aryltriazolinones
11/18/2003US6649770 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 178